CRLconf 0.70

defencath — CRL

$CRMD · CorMedix Inc.

Event date

Date TBD

Sponsor runway

cash-flow +

$178.1M liquid

Evidence

“resubmitted the New Drug Application for DefenCath to address the Complete Response Letter issued by the U.S. Food and Drug Administration a year ago”

Source: 8-K filed 2022-02-28View on EDGAR ↗0001213900-22-009595

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

No insider Form 4 activity reported on $CRMD in the 90 days around this event.

← All catalysts for $CRMD